» Articles » PMID: 27983940

Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016

Overview
Date 2016 Dec 17
PMID 27983940
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The filarial parasite Loa loa overlaps geographically with Onchocera volvulus and Wuchereria bancrofti filariae in central Africa. Accurate information regarding this overlap is critical to elimination programs targeting O. volvulus and W. bancrofti. We describe a case of loiasis in a traveler returning from Bioko Island, Equatorial Guinea, a location heretofore unknown for L. loa transmission.

Citing Articles

Unexpected Finding in an Asymptomatic Patient From The Gambia: A Case Report.

Trevino B, Zarzuela F, Oliveira-Souto I, Rubio Maturana C, Serre-Delcor N, Aznar M Open Forum Infect Dis. 2023; 10(7):ofad338.

PMID: 37484898 PMC: 10358219. DOI: 10.1093/ofid/ofad338.


Characterising co-infections with Plasmodium spp., Mansonella perstans or Loa loa in asymptomatic children, adults and elderly people living on Bioko Island using nucleic acids extracted from malaria rapid diagnostic tests.

Yoboue C, Hosch S, Donfack O, Guirou E, Nlavo B, Ondoo Ayekaba M PLoS Negl Trop Dis. 2022; 16(1):e0009798.

PMID: 35100277 PMC: 8830708. DOI: 10.1371/journal.pntd.0009798.


Interruption of onchocerciasis transmission in Bioko Island: Accelerating the movement from control to elimination in Equatorial Guinea.

Herrador Z, Garcia B, Ncogo P, Perteguer M, Rubio J, Rivas E PLoS Negl Trop Dis. 2018; 12(5):e0006471.

PMID: 29723238 PMC: 5953477. DOI: 10.1371/journal.pntd.0006471.

References
1.
Herrick J, Metenou S, Makiya M, Taylar-Williams C, Law M, Klion A . Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas. Clin Infect Dis. 2014; 60(1):55-63. PMC: 4296126. DOI: 10.1093/cid/ciu723. View

2.
Lal R, Ottesen E . Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J Infect Dis. 1988; 158(5):1034-7. DOI: 10.1093/infdis/158.5.1034. View

3.
Metzger W, Mordmuller B . Loa loa-does it deserve to be neglected?. Lancet Infect Dis. 2013; 14(4):353-7. DOI: 10.1016/S1473-3099(13)70263-9. View

4.
Bockarie M, Kelly-Hope L, Rebollo M, Molyneux D . Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges. Philos Trans R Soc Lond B Biol Sci. 2013; 368(1623):20120144. PMC: 3720042. DOI: 10.1098/rstb.2012.0144. View

5.
Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux J . Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J. 2004; 2 Suppl 1:S4. PMC: 2147657. DOI: 10.1186/1475-2883-2-S1-S4. View